IRIS
SCHENONE, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 37.816
AS - Asia 4.675
NA - Nord America 2.927
SA - Sud America 372
AF - Africa 90
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 45.888
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 37.118
US - Stati Uniti d'America 2.745
SG - Singapore 1.919
CN - Cina 1.203
VN - Vietnam 789
FR - Francia 300
BD - Bangladesh 237
BR - Brasile 220
HK - Hong Kong 164
CA - Canada 79
DE - Germania 68
FI - Finlandia 66
JP - Giappone 66
AR - Argentina 62
MX - Messico 61
IN - India 47
NL - Olanda 43
IQ - Iraq 42
GB - Regno Unito 39
ID - Indonesia 36
CH - Svizzera 30
ES - Italia 24
EC - Ecuador 23
ZA - Sudafrica 22
PK - Pakistan 20
PH - Filippine 18
RU - Federazione Russa 17
TR - Turchia 17
JO - Giordania 15
CO - Colombia 14
IE - Irlanda 14
TN - Tunisia 14
VE - Venezuela 14
CL - Cile 13
JM - Giamaica 13
PL - Polonia 13
TH - Thailandia 12
KE - Kenya 11
PY - Paraguay 11
TW - Taiwan 10
AT - Austria 9
MY - Malesia 9
SA - Arabia Saudita 9
UA - Ucraina 9
CR - Costa Rica 7
DZ - Algeria 7
LT - Lituania 7
NP - Nepal 7
RO - Romania 7
AL - Albania 6
AU - Australia 6
EG - Egitto 6
IL - Israele 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BE - Belgio 5
BO - Bolivia 5
DK - Danimarca 5
ET - Etiopia 5
LV - Lettonia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
GH - Ghana 4
HN - Honduras 4
HR - Croazia 4
KZ - Kazakistan 4
MD - Moldavia 4
SE - Svezia 4
UZ - Uzbekistan 4
BG - Bulgaria 3
GE - Georgia 3
GT - Guatemala 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
NI - Nicaragua 3
OM - Oman 3
PE - Perù 3
PR - Porto Rico 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BB - Barbados 2
BW - Botswana 2
CY - Cipro 2
GR - Grecia 2
HU - Ungheria 2
IS - Islanda 2
MM - Myanmar 2
MN - Mongolia 2
NG - Nigeria 2
PS - Palestinian Territory 2
RS - Serbia 2
AO - Angola 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
Totale 45.872
Salva come PNG Salva come JPEG
Città #
Genova 20.028
Genoa 10.663
Rapallo 3.104
Vado Ligure 2.730
Singapore 943
San Jose 807
Lauterbourg 274
Ashburn 254
Ho Chi Minh City 235
Beijing 215
Hanoi 196
Hong Kong 153
New York 148
Bordighera 92
Santa Clara 87
Council Bluffs 81
Los Angeles 75
Tokyo 63
Helsinki 60
Rome 51
Frankfurt am Main 49
Milan 40
Haiphong 37
Orem 36
Buffalo 35
Mexico City 35
Da Nang 32
Boardman 31
São Paulo 29
Atlanta 28
Zurich 25
Chicago 23
Houston 23
Turin 23
Tianjin 22
Biên Hòa 21
Amsterdam 20
Dallas 19
Montreal 19
Baghdad 18
Bologna 18
Phoenix 18
Shanghai 16
Bắc Ninh 15
Naples 15
Dublin 14
Hải Dương 14
Johannesburg 14
Amman 13
Warsaw 12
Brooklyn 11
Can Tho 11
Toronto 11
Kingston 10
Nairobi 10
Madrid 9
Cardiff 8
City of London 8
Florence 8
Nuremberg 8
Piscataway 8
Santiago 8
Thái Bình 8
Ancona 7
Bergamo 7
Changsha 7
Chennai 7
Des Moines 7
Memphis 7
Philadelphia 7
Phủ Lý 7
Salt Lake City 7
Thái Nguyên 7
Vienna 7
Bari 6
Bến Tre 6
Calgary 6
Dhaka 6
Guangzhou 6
Manchester 6
Marseille 6
Miami 6
Ninh Bình 6
Pasadena 6
Pisa 6
Rio de Janeiro 6
Savona 6
Tunis 6
Vancouver 6
Acalanes Ridge 5
Addis Ababa 5
Alessandria 5
Baku 5
Bangkok 5
Buenos Aires 5
Catania 5
Denver 5
Fortaleza 5
Guayaquil 5
Jacksonville 5
Totale 41.313
Salva come PNG Salva come JPEG
Nome #
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 352
17p11.2 duplication is a common finding in sporadic cases of charcot-marie-tooth type 1 235
Dysimmune mononeuropathies: A diagnosis not to be missed 232
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 219
Clinical epidemiology of ALS in Liguria, Italy. 217
Does parkin play a role in the peripheral nervous system? A family report 209
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies 208
Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. 207
Acute axonal form of Guillain-Barre syndrome in a multiple sclerosis patient: chance association or linked disorders? 203
HSPB1 and HSPB8 in inherited neuropathies: study of an Italian cohort of dHMN and CMT2 patients 203
A cross-sectional study investigating frequency and features of definitely diagnosed diabetic painful polyneuropathy 203
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 201
A novel mutation of GDAP1 associated with Charcot-Marie-Tooth disease in three Italian families: evidence for a founder effect 200
Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy 200
A novel compound heterozygous mutation ofC20orf54gene associated with Brown-Vialetto-Van Laere syndrome in an Italian family 199
Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain. 198
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A 197
Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study 193
A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy 193
An abnormal mRNA produced by a novel PMP22 splice site mutation associated with HNPP 192
Hereditary motor and sensory neuropathy with myelin outfolding: clinical, genetic and neuropathological study of three cases 191
Sural nerve biopsy and functional studies support the pathogenic role of a novel MPZ mutation. 191
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 190
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. 188
Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017 188
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 187
AN IN VITRO MODEL OF MYELIN PROTEIN ZERO MUTATIONS IN SCHWANN CELLS 186
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. 184
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease 184
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 184
GDAP1 mutation in autosomal recessive Charcot-Marie-Tooth with pyramidal features. 183
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22 181
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 181
Direct immunofluorescence in sural nerve biopsies. 180
Both Schwann cell and axonal defects cause motor peripheral neuropathy in Ebf2-/- mice. 180
GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical course 180
147th ENMC International Workshop: Guideline on processing and evaluation of sural nerve biopsies, 15-17 December 2006, Naarden, The Netherlands. 179
Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract 179
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 179
Guillain-Barré syndrome following chickenpox: A case series 178
Influence of comorbidities on the phenotype of patients affected by Charcot–Marie–Tooth neuropathy type 1A 177
Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years 177
GFAP expression of human Schwann cells in tissue culture. 176
A case of secondary syphilis presenting as optic neuritis 176
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. 175
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 175
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 174
Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy 174
Gain of glycosylation: a new pathomechanism of Myelin Protein Zero mutations 173
Mitichondrial dysfunction in experimental Charcot-marie-Tooth type 1° (CMTIA) neuropathy: a possible key factor for the axonal degeneration 172
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. 172
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy 171
Levodopa-induced neutropenia. 171
Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy "in disguise" 171
Early electophysiological changes in transgenic rat model of charcot-marie-tooth. 170
An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy. 170
Different movement disorders responsive to carbamazepine in patients with brainstem focal lesions 170
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 170
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. 169
[Hereditary sensory motor neuropathy: degenerative disease or a disease with an immune-mediated pathogenesis?]. 169
Testing overwork weakness in Charcot-Marie-tooth disease: Is it true or false? 169
"Limbic encephalitis with acute onset and Hu antibodies treated with rituximab: Paraneoplastic or non-paraneoplastic disorder?" 169
Impairment of central motor conduction in diabetic patients. 168
Use of cosH1 probe in hereditary neuropathy with liability to pressure palsies: a reliable genetic test for demonstration of identical size of 17p11.2 deletion in unrelated patients. 168
Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy 168
Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy. 167
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. 167
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy 166
Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease 166
Phenotypic characterization of hypomyelination and congenital cataract 165
Bannwarth syndrome: report of two cases 164
Peripheral Nerve Society Guideline on processing and evaluation of nerve biopsies. 164
Severe neuropathy after Diphtheria-Tetanus-Pertussis vaccination in a child carrying a novel frame-shift mutation in the small haet-shock protein 27 gene (HSPB1). 164
Dopamine-agonist responsive Parkinsonism in a patient with the SANDO syndrome caused by POLG mutation. 163
High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy 163
Responsiveness of gait analysis parameters in a cohort of 71 CMT subjects 163
l-Acetyl-carnitine in Patients with Carpal Tunnel Syndrome: Effects on Nerve Protection, Hand Function and Pain 163
Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype 163
Natural history of CMT1A including QoL: a 2-year prospective study. 162
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. 162
Class II antigen expression on human cultured Schwann cells from patients with Charcot-Marie-Tooth disease. 162
Outcome measures in the clinical evaluation of ambulatory Charcot Marie Tooth 1A subjects 162
The D355V mutation decreases EGR2 binding to an element within the Cx32 promoter. 160
Progressive sensory-motor polyneuropathy with tomaculous changes is associated to 17p11.2 deletion. 160
Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation 160
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. 159
Correlation among demyelination and axonal degeneration: a new trophic role for myelin sheath 159
Sonography of the median nerve in Charcot-Marie-Tooth disease 159
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 159
Expression of common acute lymphoblastic leukemia antigen (CD 10) by myelinated fibers of the peripheral nervous system. 159
Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy 159
Expanding the spectrum of genes responsible for hereditary motor neuropathies. 159
Genotype-Phenotype correlations of MPZ mutations 157
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 157
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study 156
Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings. 156
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 156
Contribution of copy number variations in CMT1X: a retrospective study. 156
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs) 156
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment 154
Totale 17.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.879
article - articoli 142.267
book - libri 0
conference - conferenze 9.849
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 763
Totale 305.758
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 0 0 0 0 0 0 161
2021/20223.627 121 259 308 425 131 206 200 824 188 329 134 502
2022/20233.728 369 338 37 380 610 627 28 246 622 27 388 56
2023/20242.404 129 263 93 326 171 415 214 161 114 68 128 322
2024/20257.123 306 480 246 482 886 679 653 1.213 339 305 700 834
2025/202612.847 1.613 415 735 917 1.772 1.040 1.927 715 850 1.377 1.252 234
Totale 46.566